Korro Bio, Inc. (KRRO) intrinsic value & 10-year financials
Korro Bio, Inc. (KRRO) has a Graham intrinsic value of $387.83 per share. At $8.49 on Oct 17, 2026, the stock trades 98% below that value. Over the last 10 fiscal years revenue shrank 22.3% a year to $6.4M, with an average return on invested capital of -54.9%.
- Graham intrinsic value
- $387.83
- Share price (Oct 17, 2026)
- $8.49
- Price vs Graham value
- 98% below
- Market cap
- $79.8M
- Revenue (FY2025)
- $6.4M
- Revenue growth (10-yr CAGR)
- -22.3%
- ROIC (10-yr avg)
- -54.9%
- Free cash flow (FY2025)
- -$79.1M
KRRO 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $6.4M | -$117.3M | -$12.48 | -$79.1M | -1906.4% | -111.4% |
| FY2024 | $2.3M | -$83.6M | -$9.37 | -$78.0M | -4047.1% | -100.3% |
| FY2023 | $0 | -$81.2M | -$8.85 | -$75.1M | — | -270.8% |
| FY2022 | $0 | -$81.6M | -$6.32 | — | — | -153.2% |
| FY2021 | $14.1M | -$84.7M | — | -$79.0M | -597.3% | -201.0% |
| FY2020 | $37.0M | -$26.5M | — | -$51.9M | -74.5% | 184.4% |
| FY2019 | $28.9M | -$18.7M | — | $33.2M | -71.4% | 33.7% |
| FY2018 | — | -$19.2M | — | -$17.5M | — | 21.3% |
| FY2017 | — | -$20.2M | — | -$16.5M | — | 103.0% |
| FY2016 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Korro Bio, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Korro Bio, Inc. has historically struggled to out-earn its cost of capital, averaging just -20.2% ROIC.
Korro Bio, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Korro Bio, Inc. is modeled at -22.3% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $387.83 per share.